SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001126234-24-000013
Filing Date
2024-02-05
Accepted
2024-02-05 17:52:48
Documents
1
Period of Report
2024-02-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1707173555.html 4  
1 FORM 4 wk-form4_1707173555.xml 4 4992
  Complete submission text file 0001126234-24-000013.txt   6578
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 512-215-2630
LUMOS PHARMA, INC. (Issuer) CIK: 0001126234 (see all company filings)

IRS No.: 421491350 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O AEGLEA BIOTHERAPEUTICS, INC. 901 S.MOPAC EXPWY,BARTONOAKSPLAZONE,#250 AUSTIN TX 78746
Business Address
Schuchart Aaron (Reporting) CIK: 0001709258 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35342 | Film No.: 24597138